TP Therapeutics

formerly Turning Point TherapeuticsAcquired

Driven to develop therapies that mark a turning point for patients

San Diego, United States · Founded 2013 · $125.0M raised

Employees
51–200
Founded
2013
Business Model
B2B
Total Funding
$125.0M
Last Round
$80.0M Series DOct 2018
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Turning Point Therapeutics (TP Therapeutics) was a clinical-stage precision oncology company based in San Diego, California, developing investigational small-molecule targeted therapies for cancer patients. Founded in 2013, the company applied structure-based drug design to engineer next-generation medicines designed to overcome resistance mechanisms that limit the effectiveness of current treatments. Its lead asset Repotrectinib (Augtyro) received FDA approval and the company was acquired by Bristol Myers Squibb in 2022 for approximately $4.1 billion.

Summary

TP Therapeutics is a Biotech company based in San Diego, United States, founded in 2013. It has raised $125.0M in total across 2 rounds, most recently a $80.0M Series D round in Oct 2018. Investors include Lilly Asia Ventures, OrbiMed and SR One.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

IPOApr 2019

Sign up to see all 3 events

Funding: Series C through Series D. Amounts, valuations, and investors where available.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

TP Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/tp-therapeutics"><img src="https://indexed.vc/api/badge/company/tp-therapeutics" alt="TP Therapeutics on Indexed.vc" width="260" height="76" /></a>